Additionally, the inclusion of R837 increased the expression of calreticulin (CRT), triggering immunogenic cell death (ICD), effectively neutralizing primary tumors, and inhibiting metastatic tumors (Figure 8a) [124]. This evidence concerns the gene CALR and metastatic neoplasm.